Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP815749.RAUlgznf05mOOLpXfwzUYoF-Y3vuL3xp6g6FonJH6D9ao130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815749.RAUlgznf05mOOLpXfwzUYoF-Y3vuL3xp6g6FonJH6D9ao130_provenance.
• NP414622.RAf4NsKhUjHme33j0jBCC5xhsMuIWAmeOKEdsnCqJ1vtw130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414622.RAf4NsKhUjHme33j0jBCC5xhsMuIWAmeOKEdsnCqJ1vtw130_provenance.
• NP498336.RAjwA9R-mXeZeVJJfep-q7UqxnGlvtjMrDGnMAKQdY-Jw130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498336.RAjwA9R-mXeZeVJJfep-q7UqxnGlvtjMrDGnMAKQdY-Jw130_provenance.
• assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP556228.RAxsrCo-kquJGLu93uwLHtTulwwQCUrGL2MpTRaYTalYw130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556228.RAxsrCo-kquJGLu93uwLHtTulwwQCUrGL2MpTRaYTalYw130_provenance.
• assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP294217.RAdrQ2pRf0xKvw-7Ko5FIsl4IJlDDjVNBgkkjwygAi75U130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294217.RAdrQ2pRf0xKvw-7Ko5FIsl4IJlDDjVNBgkkjwygAi75U130_provenance.
• NP610218.RAVrov7y9roYJoCrET1rFPiLWDW-yuuG4f84idgvevJLQ130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610218.RAVrov7y9roYJoCrET1rFPiLWDW-yuuG4f84idgvevJLQ130_provenance.
• assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP933096.RAfl13BHrrpFvkpvJDmYqnIhd02_D_MhzJkQHf9dUg0qQ130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933096.RAfl13BHrrpFvkpvJDmYqnIhd02_D_MhzJkQHf9dUg0qQ130_provenance.
• NP292411.RAsmdf6pQXDo47uIiJPq7_YTW3N9VhDaKog0u3CBzTcg4130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292411.RAsmdf6pQXDo47uIiJPq7_YTW3N9VhDaKog0u3CBzTcg4130_provenance.
• NP933094.RACLRrQpygMI3tRAp2hvtVtkWe-QteJjsnUfKWoKWFvs0130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933094.RACLRrQpygMI3tRAp2hvtVtkWe-QteJjsnUfKWoKWFvs0130_provenance.
• NP933095.RAD9a69Vkjy4Tlr8H8IljpBv25XqtoZXiw21NnQWTj838130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933095.RAD9a69Vkjy4Tlr8H8IljpBv25XqtoZXiw21NnQWTj838130_provenance.
• NP845306.RAOUZRhjpq8QXkQFLSiIRLuGtELShrQye3xmap8boANdI130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845306.RAOUZRhjpq8QXkQFLSiIRLuGtELShrQye3xmap8boANdI130_provenance.
• NP933093.RAuijW-JHxsEx9-gKiBmkG-yRHKxxpzz9gNo4L7VZ_SF4130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933093.RAuijW-JHxsEx9-gKiBmkG-yRHKxxpzz9gNo4L7VZ_SF4130_provenance.
• NP414832.RA_w4vcZqPxHkWL5b2xB87S5KzpkP7oWdIZM5vc1nnxXY130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414832.RA_w4vcZqPxHkWL5b2xB87S5KzpkP7oWdIZM5vc1nnxXY130_provenance.
• NP290811.RAM349zQANqLo5mAF-XqkZonxj58E9qAL5jy3M5-pqNso130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290811.RAM349zQANqLo5mAF-XqkZonxj58E9qAL5jy3M5-pqNso130_provenance.
• NP933092.RAPY6gUh5RbrlGustqm7cuxj5l3UAkjdhv7e-JEjOPq_0130_assertion description "[As upregulation of CD99 led to a decrease in cHL diagnosis marker CD30 and CD15 and an increase in plasma-cell differentiation marker CD38 and the restoration of B-cell makers PAX5, CD79? and CD19, we suggest that downregulated CD99 leads to the prevention of plasma-cell differentiation in Hodgkin/Reed-Sternberg (H/RS) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933092.RAPY6gUh5RbrlGustqm7cuxj5l3UAkjdhv7e-JEjOPq_0130_provenance.